Skip to main content
Log in

Impact of intracellular chloride concentration on cisplatin accumulation in sensitive and resistant GLC4 cells

  • Original Paper
  • Published:
JBIC Journal of Biological Inorganic Chemistry Aims and scope Submit manuscript

Abstract

Resistance to cisplatin [cis-diamminedichloroplatinum(II), CDDP] chemotherapy is a major problem in the clinic. Understanding the molecular basis of the intracellular accumulation of CDDP and other platinum-based anticancer drugs is of importance in delineating the mechanism of resistance to these clinically important therapies. Different molecular mechanisms may coexist, but defective uptake of CDDP is one of the most consistently identified characteristics of cells selected for CDDP resistance. We have studied the impact of intracellular chloride concentration on platinum-based compound accumulation in the human GLC4, GLC4/CDDP, and K562 tumor cell lines. We show that (1) a decrease of intracellular chloride concentration yielded an increase of CDDP accumulation and vice versa and (2) the intracellular chloride concentration in GLC4/CDDP cells is higher than in sensitive cells, whereas CDDP accumulation shows the opposite behavior. The identification of chloride as a critical determinant of CDDP intracellular accumulation and the molecular mechanisms by which CDDP-resistant cells modulate chloride concentration may allow alternative therapeutic approaches. Our findings indicate that increase of intracellular chloride concentration may be a major determinant of CDDP resistance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Brenner J, Magill GB, Sordillo PP, Cheng EW, Yagoda A (1982) Cancer 50:2031–2033

    Article  PubMed  CAS  Google Scholar 

  2. Rozencweig M, von Hoff DD, Slavik M, Muggia FM (1977) Ann Intern Med 86:803–812

    PubMed  CAS  Google Scholar 

  3. Kartalou M, Essigmann JM (2001) Mutat Res 478:23–43

    PubMed  CAS  Google Scholar 

  4. Wernyj RP, Morin PJ (2004) Drug Resist Update 7:227–232

    Article  CAS  Google Scholar 

  5. Wang D, Lippard SJ (2005) Nat Rev Drug Discov 4:307–320

    Article  PubMed  CAS  Google Scholar 

  6. Kelland LR (2000) Drug Resist Update 3:139–141

    Article  CAS  Google Scholar 

  7. Baird RD, Kaye SB (2003) Eur J Cancer 39:2450–2461

    Article  PubMed  CAS  Google Scholar 

  8. Oldenburg J, Begg AC, van Vugt MJ, Ruevekamp M, Schornagel JH, Pinedo HM, Los G (1994) Cancer Res 54:487–493

    PubMed  CAS  Google Scholar 

  9. Andrews PA, Howell SB (1990) Cancer Cells 2:35–43

    PubMed  CAS  Google Scholar 

  10. Gately DP, Howell SB (1993) Br J Cancer 67:1171–1176

    PubMed  CAS  Google Scholar 

  11. Pereira-Maia E, Garnier-Suillerot A (2003) J Biol Inorg Chem 8:626–634

    Article  PubMed  CAS  Google Scholar 

  12. Lee EL, Shimizu T, Ise T, Numata T, Kohno K, Okada Y (2007) J Cell Physiol 211:513–521

    Article  PubMed  CAS  Google Scholar 

  13. Zijlstra JG, de Vries EG, Mulder NH (1987) Cancer Res 47:1780–1784

    PubMed  CAS  Google Scholar 

  14. Hospers GA, Mulder NH, de Jong B, de Ley L, Uges DR, Fichtinger-Schepman AM, Scheper RJ, de Vries EG (1988) Cancer Res 48:6803–6807

    PubMed  CAS  Google Scholar 

  15. Lozzio CB, Lozzio BB (1975) Blood 45:321–334

    PubMed  CAS  Google Scholar 

  16. Lim MC, Martin RB (1976) J Inorg Nucl Chem 38:1911

    Article  CAS  Google Scholar 

  17. Piwnica-Worms D, Jacob R, Horres CR, Lieberman M (1983) J Gen Physiol 81:731–748

    Article  PubMed  CAS  Google Scholar 

  18. Verkman AS, Sellers MC, Chao AC, Leung T, Ketcham R (1989) Anal Biochem 178:355–361

    Article  PubMed  CAS  Google Scholar 

  19. Garcia MA, Meizel S (1999) J Androl 20:88–93

    PubMed  CAS  Google Scholar 

  20. El-Khateeb M, Appleton TG, Charles BG, Gahan LR (1999) J Pharm Sci 88:319–326

    Article  PubMed  CAS  Google Scholar 

  21. Dzamitika S, Salerno M, Pereira-Maia E, Le Moyec L, Garnier-Suillerot A (2006) J Bioenerg Biomembr 38:11–21

    Article  PubMed  CAS  Google Scholar 

  22. Chao AC, Dix JA, Sellers MC, Verkman AS (1989) Biophys J 56:1071–1081

    Article  PubMed  CAS  Google Scholar 

  23. Koncz C, Daugirdas JT (1994) Am J Physiol 267:H2114–H2123

    PubMed  CAS  Google Scholar 

  24. Amorino GP, Fox MH (1996) J Membr Biol 152:217–222

    Article  PubMed  CAS  Google Scholar 

  25. Huang H, Zhu L, Reid BR, Drobny GP, Hopkins PB (1995) Science 270:1842–1845

    Article  PubMed  CAS  Google Scholar 

  26. Jiang S, Song MJ, Shin EC, Lee MO, Kim SJ, Park JH (1999) Hepatology 29:101–110

    Article  PubMed  CAS  Google Scholar 

  27. Wang D, Lippard SJ (2004) J Biol Chem 279:20622–20625

    Article  PubMed  CAS  Google Scholar 

  28. Berners-Price SJ, Ronconi L, Sadler PJ (2006) Prog Nucl Magn Reson Spectrosc 49:65–98

    Google Scholar 

  29. Kishimoto S, Kawazoe Y, Ikeno M, Saitoh M, Nakano Y, Nishi Y, Fukushima S, Takeuchi Y (2006) Cancer Chemother Pharmacol 57:84–90

    Article  PubMed  CAS  Google Scholar 

  30. Kalayda GV, Zhang G, Abraham T, Tanke HJ, Reedijk J (2005) J Med Chem 48:5191–5202

    Article  PubMed  CAS  Google Scholar 

  31. Miller SE, House DA (1989) Inorg Chim Acta 161:131–137

    Article  CAS  Google Scholar 

  32. Berners-Price SJ, Apleton TG (2000) In: Kelland LR, Farrell NP (ed) Platinum-based drugs in cancer therapy. Humana Press, Totowa, pp 3–35

  33. Reedijk J, Teuben JM (1999). In: Lippert B (ed) Cisplatin: chemistry and biochemistry of a leading anticancer drug. Wiley, Weinheim, pp 339–362

  34. Bose RN, Ghosh SK, Moghaddas S (1997) J Inorg Biochem 65:199–205

    Article  PubMed  CAS  Google Scholar 

  35. Kelland L (2007) Nat Rev Cancer 7:573–584

    Article  PubMed  CAS  Google Scholar 

  36. Dabrowiak JC, Goodisman J, Souid AK (2002) Drug Metab Dispos 30:1378–1384

    Article  PubMed  CAS  Google Scholar 

  37. Berners-Price S, Kuchel PW (1990) J Inorg Biochem 38:327–345

    Article  CAS  Google Scholar 

  38. Berners-Price S, Kuchel P (1990) J Inorg Chem 38:305–326

    CAS  Google Scholar 

  39. Ishikawa T, Ali-Osman F (1993) J Biol Chem 268:20116–20125

    PubMed  CAS  Google Scholar 

  40. Arner ES, Nakamura H, Sasada T, Yodoi J, Holmgren A, Spyrou G (2001) Free Radic Biol Med 31:1170–1178

    Article  PubMed  CAS  Google Scholar 

  41. Jennerwein M, Andrews PA (1995) Drug Metab Dispos 23:178–184

    PubMed  CAS  Google Scholar 

  42. Yarbrough JW, Merryman JI, Barnhill MA, Hahn KA (1999) In Vivo 13:375–383

    PubMed  CAS  Google Scholar 

  43. Kawabe T, Chen ZS, Wada M, Uchiumi T, Ono M, Akiyama S, Kuwano M (1999) FEBS Lett 456:327–331

    Article  PubMed  CAS  Google Scholar 

  44. Nakayama K, Miyazaki K, Kanzaki A, Fukumoto M, Takebayashi Y (2001) Oncol Rep 8:1285–1287

    PubMed  CAS  Google Scholar 

  45. Komatsu M, Sumizawa T, Mutoh M, Chen ZS, Terada K, Furukawa T, Yang XL, Gao H, Miura N, Sugiyama T, Akiyama S (2000) Cancer Res 60:1312–1316

    PubMed  CAS  Google Scholar 

  46. Song IS, Savaraj N, Siddik ZH, Liu P, Wei Y, Wu CJ, Kuo MT (2004) Mol Cancer Ther 3:1543–1549

    PubMed  CAS  Google Scholar 

  47. Beretta GL, Gatti L, Tinelli S, Corna E, Colangelo D, Zunino F, Perego P (2004) Biochem Pharmacol 68:283–291

    Article  PubMed  CAS  Google Scholar 

  48. Holzer AK, Samimi G, Katano K, Naerdemann W, Lin X, Safaei R, Howell SB (2004) Mol Pharmacol 66:817–823

    Article  PubMed  CAS  Google Scholar 

  49. Holzer AK, Katano K, Klomp LW, Howell SB (2004) Clin Cancer Res 10:6744–6749

    Article  PubMed  CAS  Google Scholar 

  50. Zisowsky J, Koegel S, Leyers S, Devarakonda K, Kassack MU, Osmak M, Jaehde U (2007) Biochem Pharmacol 73:298–307

    Article  PubMed  CAS  Google Scholar 

  51. Guo Y, Smith K, Petris MJ (2004) J Biol Chem 279:46393–46399

    Article  PubMed  CAS  Google Scholar 

  52. Owatari S, Akune S, Komatsu M, Ikeda R, Firth SD, Che XF, Yamamoto M, Tsujikawa K, Kitazono M, Ishizawa T, Takeuchi T, Aikou T, Mercer JF, Akiyama S, Furukawa T (2007) Cancer Res 67:4860–4868

    Article  PubMed  CAS  Google Scholar 

  53. Kabolizadeh P, Ryan J, Farrell N (2007) Biochem Pharmacol 73:1270–1279

    Article  PubMed  CAS  Google Scholar 

  54. Safaei R, Katano K, Samimi G, Naerdemann W, Stevenson JL, Rochdi M, Howell SB (2004) Cancer Chemother Pharmacol 53:239–246

    Article  PubMed  CAS  Google Scholar 

  55. Safaei R, Holzer A, Katano K, Samimi G, Howell S (2004) J Inorg Biochem 98:1607–1613

    Article  PubMed  CAS  Google Scholar 

  56. Beretta GL, Righetti SC, Lombardi L, Zunino F, Perego P (2002) Ultrastruct Pathol 26:331–334

    Article  PubMed  Google Scholar 

  57. Russell JM (2000) Physiol Rev 80:211–276

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This research was supported by grants from Université Paris 13 and CNRS. We thank to Ricarda Riina for her help.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Milena Salerno.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Salerno, M., Yahia, D., Dzamitika, S. et al. Impact of intracellular chloride concentration on cisplatin accumulation in sensitive and resistant GLC4 cells. J Biol Inorg Chem 14, 123–132 (2009). https://doi.org/10.1007/s00775-008-0430-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00775-008-0430-3

Keywords

Navigation